The newly released GLASS dashboard displays a comprehensive range of AMR and AMU data through 2021. 

It facilitates data visualization and supplements GLASS yearly reports.

The GLASS dashboard summarises resistance rates for twenty-three medications in eleven antibacterial classes, spanning eight bacterial pathogens usually isolated from patients with circulatory, gastrointestinal, urinary, or genital infectious disorders.

The number of countries enrolling and reporting data on antimicrobial use to GLASS has grown over time, and WHO is working with governments to expand even more. 

Continuous efforts are made to improve both data quality and user experience.

WHO is preparing a handbook on using AMU surveillance data for policy and practice, which will be published by the end of 2024.